BRITTNEY KOOPMAN: Open Payments
NPI 1760084057 · INDIANAPOLIS, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$464 in 11 payments from 10 companies in 2025. Trend: 2023 $169 · 2024 $605 · 2025 $464
Food & beverage: $464
| Company | Payments | Amount |
|---|---|---|
| COLOPLAST CORP | 1 | $135 |
| Janssen Biotech, Inc. | 1 | $133 |
| AstraZeneca Pharmaceuticals LP | 2 | $32 |
| Smith+Nephew, Inc. | 1 | $29 |
| Mallinckrodt Hospital Products Inc. | 1 | $25 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $25 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $24 |
| Grifols USA, LLC | 1 | $23 |
| Davol Inc. | 1 | $21 |
| Regeneron Healthcare Solutions, Inc. | 1 | $17 |
Products named: Biatain Ag Non-Adhesive, TREMFYA, GRAFIX PL, ACTHAR, OFEV, GLASSIA, Prolastin-C Liquid, ARISTA.
Industry payments across IN — which companies pay providers there.
